Case Study: AggreGuard improves viral kinetics in measles process
Enhancement Potential for a Classical Batch-Mode Upstream Measles Process*: Impact of AggreGuard™ AggreGuard™, a CellRev product, was independently evaluated in a commercially relevant measles vaccine process without altering standard operating protocol, showing: ↓ cell-to-cell adhesion and ↑ cell culture homogeneity. ↓ glucose/glutamine consumption and ↓ lactate/ammonia production. ↑ viral infection kinetics and ↓ time to …
Case Study: AggreGuard improves viral kinetics in measles process Read More »